Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,163 | -1,985 | -1,084 | -5,828 | -5,000 |
| Depreciation Amortization | 546 | 388 | 224 | 765 | 548 |
| Accounts receivable | 7 | 24 | 2 | 110 | 67 |
| Accounts payable and accrued liabilities | -91 | -35 | -77 | 109 | 30 |
| Other Working Capital | 87 | 87 | -46 | 1,338 | 261 |
| Other Operating Activity | 1,472 | 819 | 527 | 3,018 | 3,135 |
| Operating Cash Flow | $-1,141 | $-701 | $-453 | $-487 | $-959 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -225 | -225 | -225 | -675 | N/A |
| Purchase Sale Intangibles | -1,000 | -500 | -500 | N/A | N/A |
| Other Investing Activity | -1,000 | -500 | -500 | 0 | 0 |
| Investing Cash Flow | $-1,228 | $-725 | $-725 | $-675 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,809 | 1,334 | 65 | 968 | 756 |
| Debt Repayment | -254 | -101 | 926 | -19 | -15 |
| Common Stock Issued | 110 | 110 | 110 | 348 | 348 |
| Financing Cash Flow | $2,666 | $1,342 | $1,101 | $1,297 | $1,089 |
| Beginning Cash Position | 136 | 136 | 136 | 1 | 1 |
| End Cash Position | 432 | 52 | 58 | 136 | 131 |
| Net Cash Flow | $296 | $-84 | $-78 | $135 | $130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,141 | -701 | -453 | -487 | -959 |
| Capital Expenditure | -3 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,145 | -701 | -453 | -487 | -959 |